Rita A. Sakr

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

Weiyi Toy, Yang Shen, Helen Won et al. · Nature Genetics · 2013 · 1.2K citations · Full text

Breast Oncology, Hormone-resistant Breast Cancer, Breast Cancer +5

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 649 citations · Full text

Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy

Tari A. King, Rita A. Sakr, Sujata Patil et al. · Journal of Clinical Oncology · 2011 · 324 citations · Full text

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

Sarat Chandarlapaty, Rita A. Sakr, Dilip D. Giri et al. · Clinical Cancer Research · 2012 · 221 citations

Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands

Ilan Weinreb, Salvatore Piscuoglio, Luciano G. Martelotto et al. · Nature Genetics · 2014 · 212 citations · Full text

Perineural Invasion, Polymorphous Low-grade Adenocarcinomas, Pathology +6